IFNG and COVID-19: Furthermore, COVID-19 alters tryptophan metabolism, in which IFN-γ-regulated IDO catalyzes the conversion of tryptophan to kynurenine, thus leading to reduced tryptophan and weakened antitumor capabilities (165).